| 3D | Three-dimensional |
| AAV | Adeno-associated virus |
| ABA | Applied behavior analysis |
| ABAS | Adaptive Behavior Assessment System |
| ABC | Aberrant Behavior Checklist |
| ABC-CT | Autism Biomarkers Consortium for Clinical Trials |
| ACB | Autologous cord blood |
| AD | Adipose tissue |
| ADDM | Autism and Developmental Disabilities Monitoring |
| ADI-R | Autism Diagnostic Interview-Revised |
| AD-MSC | Adipose tissue-derived mesenchymal stromal cell |
| Akt | Protein kinase B |
| AM | Amniotic membrane |
| Anti-HBc | Hepatitis B core antibody |
| Anti-HBs | Hepatitis B surface antibody |
| APRICOT | Anaesthesia PRactice In Children Observational Trial |
| ARDS | Acute respiratory distress syndrome |
| ASD | Autism spectrum disorder |
| ATEC | Autism Treatment Evaluation Checklist |
| ATMP | Advanced therapy medicinal product |
| B7-H1 | B7 homolog 1 |
| Bax | Bcl-2-associated X protein |
| BBB | Blood–brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BEST | Biomedical Excellence for Safer Transfusion |
| BM | Bone marrow |
| BMMNC | Bone marrow mononuclear cells |
| BM-MSC | Bone marrow-derived mesenchymal stromal cell |
| CARS | Childhood Autism Rating Scale |
| CARS-2 | Childhood Autism Rating Scale, Second Edition |
| Caspase | Cysteine-aspartic protease |
| CBMNC | Cord blood mononuclear cell |
| CBT | Cognitive behavioral therapy |
| CD | Cluster of differentiation |
| CDC | Centers for Disease Control and Prevention |
| CFU-F | Colony-forming unit-fibroblast |
| CGI | Clinical Global Impression |
| cGMP | Current Good Manufacturing Practice |
| CI | Confidence interval |
| CNS | Central nervous system |
| COVID-19 | Coronavirus disease 2019 |
| CP | Cerebral palsy |
| CSF | Cerebrospinal fluid |
| CUMS | Chronic unpredictable mild stress |
| Denver II | Denver Developmental Screening Test, Second edition |
| DMSO | Dimethyl sulfoxide |
| EBMT | European Society for Blood and Marrow Transplantation |
| EEG | Electroencephalography |
| EGF | Epidermal growth factor |
| EOWPVT | Expressive One Word Picture Vocabulary Test, Fourth edition |
| EP2 | Prostaglandin E2 receptor subtype 2 |
| EP4 | Prostaglandin E2 receptor subtype 4 |
| EV | Extracellular vesicles |
| FBS | Fetal bovine serum |
| FDA | Food and Drug Administration |
| FGF | Fibroblast growth factor |
| FIM | Functional Independence Measure |
| FLT1 | Fms-related tyrosine kinase 1 |
| FMEA | Failure mode and effects analysis |
| FoxP3 | Forkhead box P3 |
| GABA | Gamma-aminobutyric acid |
| GAG | Glycosaminoglycan |
| GAP-43 | Growth-associated protein 43 |
| GARS-II | Gilliam Autism Rating Scale, Second Edition |
| GDNF | Glial cell line-derived neurotrophic factor |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| GMFM-66 | Gross Motor Function Measure-66 |
| GMP | Good Manufacturing Practice |
| GVHD | Graft-versus-host disease |
| H&E | Hematoxylin and eosin |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HGF | Hepatocyte growth factor |
| HIV | Human immunodeficiency virus |
| HLA | Human leukocyte antigen |
| HLA-ABC | Human leukocyte antigen class I (A, B, and C) |
| HLA-DR | Human leukocyte antigen-DR isotype |
| HLA-G | Human leukocyte antigen-G |
| HPL | Human platelet lysate |
| HTLV | Human T-cell lymphotropic virus |
| HUCPV | Human umbilical cord perivascular |
| ICS | Individualized combination supplements |
| ICV | Intracerebroventricular |
| ID | Intellectual disability |
| IDO | Indoleamine 2,3-dioxygenase |
| IFNG-AS1 | Interferon gamma antisense RNA 1 |
| IFN-γ | Interferon-gamma |
| IGF-1 | Insulin-like growth factor-1 |
| IGF-1R | Insulin-like growth factor-1 receptor |
| IL | Interleukin |
| IL-1Ra | Interleukin-1 receptor antagonist |
| iPSC | Induced pluripotent stem cell |
| IQ | Intelligence Quotient |
| ISAA | Indian Scale for Assessment of Autism |
| ISCT | International Society for Cellular Therapy |
| IT | Intrathecal |
| IV | Intravenous |
| JAKE | Janssen Autism Knowledge Engine |
| LPS | Lipopolysaccharide |
| MAPC | Multipotent adult progenitor cell |
| MCB | Master cell bank |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDC | Macrophage-derived chemokine |
| MHC | Major histocompatibility complex |
| MIA | Maternal immune activation |
| miR-21a-3p | MicroRNA-21a-3p |
| MMP | Matrix metalloproteinase |
| mRNA | Messenger RNA |
| MSC | Mesenchymal stromal cell |
| MSEC | Mental Synthesis Evaluation Checklist |
| mTOR | Mechanistic target of rapamycin |
| NAT | Nucleic acid testing |
| NF-κB | Nuclear factor kappa B |
| NGF | Nerve growth factor |
| NK | Natural killer |
| NLRP3 | Nucleotide oligomerization domain-like receptor protein 3 |
| NOD | Non-obese diabetic |
| NSE | Neuron-specific enolase |
| NT-3 | Neurotrophin-3 |
| OA | Osteoarthritis |
| OCT | Octamer-binding transcription factor |
| OMI | Oculomotor Index of Gaze to Human Faces |
| PACT | Production Assistance for Cellular Therapies |
| PDD | Pervasive Developmental Disorder |
| PDGF | Platelet-derived growth factor |
| PDMS-2 | Peabody Developmental Motor Scales-2 Gross Motor Quotient |
| PET | Positron emission tomography |
| PGE2 | Prostaglandin E2 |
| pHPL | Pooled human platelet lysate |
| PI3K | Phosphoinositide 3-kinase |
| Poly I:C | Polyinosinic-polycytidylic acid |
| PTEN | Phosphatase and tensin homolog |
| PV | Perivascular |
| RBS-R | Repetitive Behavior Scale-Revised |
| RCT | Randomized controlled trial |
| RDoC | Research Domain Criteria |
| REX1 | Reduced expression protein 1 |
| RORγt | Retinoic acid receptor-related orphan nuclear receptor gamma t |
| RR | Relative risk |
| SA | Sub-amnion |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SCID | Severe combined immunodeficiency |
| SCQ | Social Communication Questionnaire |
| SEED | Study to Explore Early Development |
| SMD | Standardized mean difference |
| SOX | SRY-box transcription factor |
| SRS | Social Responsiveness Scale |
| SSEA | Stage-specific embryonic antigen |
| SSRI | Selective serotonin reuptake inhibitor |
| STR | Stirred-tank bioreactor |
| SYP | Synaptophysin |
| TARC | Thymus and activation-regulated chemokine |
| TGF-β1 | Transforming growth factor-beta 1 |
| Th | T-helper |
| TLR | Toll-like receptor |
| TNCC | Total nucleated cell count |
| TNF-α | Tumor necrosis factor-alpha |
| Treg | Regulatory T cell |
| TREM-2 | Triggering receptor expressed on myeloid cells-2 |
| TRM | Treatment-related mortality |
| TSPO | Translocator protein |
| UCB | Umbilical cord blood |
| UC-MSC | Umbilical cord-derived mesenchymal stromal cell |
| US | United States |
| USV | Ultrasonic vocalization |
| VABS-3 | Vineland Adaptive Behavior Scales, Third Edition |
| VABS-II | Vineland Adaptive Behavior Scales, Second Edition |
| VEGF | Vascular endothelial growth factor |
| VPA | Valproic acid |
| WeeFIM | Functional Independence Measure for Children |
| WHO | World Health Organization |
| WJ | Wharton’s jelly |
| WJ-MSC | Wharton’s jelly-derived mesenchymal stromal cell |
| WMD | Weighted mean difference |
| WOMAC | Western Ontario and McMaster Universities Osteoarthritis Index total outcomes |